Panicle Pharmaceuticals Private Limited

Panicle Pharmaceuticals Private Limited - chemicals in Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2019PTC346819 Incorporated 01 March 2019 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹80.26 Lakh
▲ 9% YoY
Net profit · FY 2025
₹70,625
Net margin 0.9%
EBITDA · FY 2025
₹1.02 Lakh
EBITDA margin 1.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Panicle Pharmaceuticals Private Limited

Data last updated:

Panicle Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 01 March 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC346819. Its GSTIN is 09AAKCP4089M1ZL (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kaseem Ahmad and Shama Praveen.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 0 – 175 3rd Floor Gali No.4 Sunder Nagari Near Noorani Masjid, Delhi, India – 110093.

As per the financials filed for FY 2025, the company reported a revenue of ₹80.26 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹70,625 (net margin 0.9%) and EBITDA of ₹1.02 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 26% over five years.

Company details

CIN U24230DL2019PTC346819
Registration Number 346819
Incorporation Date 01 March 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Panicle Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    0 – 175 3rd Floor Gali No.4 Sunder Nagari Near Noorani Masjid, Delhi, India – 110093
  • Industry
    Chemicals, Manufacturing, Other Chemical Product

To see the full contact details of Panicle Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Panicle Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Panicle Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Panicle Pharmaceuticals Private Limited, buy the company report.

Financials of Panicle Pharmaceuticals Private Limited

FY 2025 filings available

Panicle Pharmaceuticals Private Limited reported revenue of ₹80.26 Lakh (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹80.26 Lakh ▲ 9%
Net profit · FY 2025
₹70,625 margin 0.9%
EBITDA · FY 2025
₹1.02 Lakh margin 1.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 21%
5 years · compounded
▲ 26%
EBITDA CAGR growth
1 year
▲ 48%
3 years · compounded
▲ 46%
5 years · compounded
▲ 8%

Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 9% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.02 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹70,625
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.3%
Net Profit Margin0.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Panicle Pharmaceuticals Private Limited, buy the company report.

Board of directors of Panicle Pharmaceuticals Private Limited

Panicle Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Kaseem AhmadDirector01 Mar 20197 Years 7 MonthsCurrent
Shama PraveenDirector01 Mar 20197 Years 7 MonthsCurrent

Peer comparison

Panicle Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Cypress Pharmaceuticals Private Limited₹80.44 Lakh (FY 2020)-84.0%Mumbai, Maharashtra, India
Medyur Pharmaceuticals Limited₹80.41 Lakh (FY 2025)68.0%New Delhi, Delhi, India
Loyol Pharmaceuticals Private Limited₹80.32 Lakh (FY 2021)Balasore, Odisha, India
Panicle Pharmaceuticals Private Limitedthis company₹80.26 Lakh (FY 2025)₹70,6250.9%9.0%Delhi, India
Genmission Pharmaceuticals Private Limited₹79.86 Lakh (FY 2025)52.0%New Delhi, Delhi, India

To see the full peer comparison of Panicle Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Panicle Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Panicle Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAKCP4089M1ZLUttar PradeshActive14 May 2019

To see the full GST registrations and return filing status of Panicle Pharmaceuticals Private Limited, buy the company report.

Recent activity

Panicle Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Kaseem Ahmad was appointed as Director on 01 Mar 2019.

AGM
Panicle Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Panicle Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Kaseem Ahmad was appointed as Director.
Appointed
Shama Praveen was appointed as Director.
Incorporation
01 Mar 2019
Panicle Pharmaceuticals Private Limited was registered on 01 Mar 2019 with Roc Delhi I & aged 7 years 7 months as per MCA records.

Frequently asked questions

Panicle Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 01 March 2019 (7+ years old) and is registered under CIN U24230DL2019PTC346819.

Panicle Pharmaceuticals has 2 current directors:

The latest financial statements of Panicle Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Panicle Pharmaceuticals is 09AAKCP4089M1ZL, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Panicle Pharmaceuticals is U24230DL2019PTC346819. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Panicle Pharmaceuticals was incorporated on 01 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Panicle Pharmaceuticals by revenue are Cypress Pharmaceuticals Private Limited, Medyur Pharmaceuticals Limited, Loyol Pharmaceuticals Private Limited, Genmission Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Kaseem Ahmad was appointed as Director on 01 Mar 2019. Shama Praveen was appointed as Director on 01 Mar 2019.

The registered office of Panicle Pharmaceuticals is at 0 – 175 3rd Floor Gali No.4 Sunder Nagari Near Noorani Masjid, Delhi, India – 110093.

Panicle Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Panicle Pharmaceuticals can be reached at its registered office: 0 – 175 3rd Floor Gali No.4 Sunder Nagari Near Noorani Masjid, Delhi, India – 110093.